PPlutux
SystemsBoardsJournalsStocksInsightsPricingResources
SystemsBoardsJournalsStocksInsightsPricingResourcesMore
Price ActionOverviewFundamental AnalysisKey MetricsFinancial HighlightsFinancial StatementsCalendarLeadership TeamCEO ProfileEarnings Call TranscriptsRecent NewsEmployee CountKey ProductsSupply ChainInsider Transactions
About Us•Privacy Policy•Terms of Service•Disclaimer•Stock Directory•ETFs•Indices•13F Holdings•Analyst Targets•Free Tools•Technology Map•Join our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026
Indicators
Moving Averages
Momentum
Oscillator
Volume
Fibonacci
GSK plc logo

GSK plc

GSK
$49.97
-1.77%-$0.90
High—
Low—
52W High-16.9%
Rel. vol—
High—
Low—
52W High-16.9%
Rel. vol—
Interval
Range73m
IndicatorsVolume—SMA5SMA10
—

AI analysis

GSK plc is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

  • Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
  • Breakdown risk rises if support fails with accelerating sell volume.
  • Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5
$49.89
5-period simple moving average
SMA10
$49.91
10-period simple moving average
SMA20
$49.89
20-period simple moving average
SMA50
—
50-period simple moving average
EMA5
$49.89
5-period exponential moving average
EMA10
$49.90
10-period exponential moving average
EMA20
$49.90
20-period exponential moving average
DEMA20
$49.89
Double exponential moving average
Fibonacci
Retracement
Retracement levels
VWAP
$49.90
Volume weighted average price
MACD
-0.005
Signal -0.004
RSI(14)
50.0
Relative strength oscillator
OBV
-3.89K
On-balance volume
StochRSI
50.0 / 50.0
Fast oscillator pair
BBands Low
$49.81
Lower band
BBands Mid
$49.89
Middle band
BBands High
$49.98
Upper band
Market Cap
101.92B
Company size
P/E Ratio
15.86
Valuation multiple
EV / EBITDA
9.31
Enterprise value multiple
ROE
33.4%
Return on equity
ROA
10.0%
Return on assets
Operating Margin
30.9%
Operating efficiency
Net Margin
14.5%
Bottom-line profitability
Current Ratio
—
Short-term liquidity
Debt / Equity
—
Balance-sheet leverage
Dividend Yield
3.6%
Income yield
FCF Yield
—
Free cash flow yield
Beta
0.29
Market sensitivity
52W High
$60.11
52-week peak
52W Low
$37.95
52-week trough

Supply Chain of GSK

Upstream / Downstream / Proxies

Upstream

12
Bora Pharmaceuticals Co., Ltd.TWSE:6472Samsung Biologics Co., Ltd.KRX:207940Lonza Group AGSIX:LONNThermo Fisher Scientific Inc. (Patheon brand)NYSE:TMOWuXi Biologics (Cayman) Inc.HKEx:2269Croda International PlcLSE:CRDAPiramal Pharma Ltd (Piramal Pharma Solutions)NSE:PPLPHARMADesano Pharmaceuticals Co., Ltd.Catalent, Inc. (now private, owned by Novo Holdings)Danaher CorporationNYSE:DHRSartorius AGXETRA:SRT.DEMerck KGaA (Germany)XETRA:MRK.DE

Downstream

10
Cencora, Inc. (formerly AmerisourceBergen)NYSE:CORCardinal Health, Inc.NYSE:CAHMcKesson CorporationNYSE:MCKAnda Pharmaceuticals (subsidiary of Teva Pharmaceutical Industries)Capital Wholesale Drug CompanyCVS Health CorporationNYSE:CVSWalgreens Boots Alliance, Inc.NASDAQ:WBAUnitedHealth Group Inc. (OptumRx)NYSE:UNHThe Cigna Group (Express Scripts)NYSE:CIViiV Healthcare (consolidated JV)

Proxies

6
AstraZeneca plcLSE:AZNSanofi S.A.EURONEXT:SANMerck & Co., Inc.NYSE:MRKPfizer Inc.NYSE:PFEBora Pharmaceuticals Co., Ltd.TWSE:6472Croda International PlcLSE:CRDA
Stocks